SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-009122
Filing Date
2020-04-14
Accepted
2020-04-14 08:58:53
Documents
6
Period of Report
2020-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120649-8k_immucellcorp.htm 8-K 19739
2 PRESS RELEASE OF THE COMPANY DATED APRIL 14, 2020 ea120649ex99-1_immucellcorp.htm EX-99.1 17646
3 PROMISSORY NOTE FOR $937,700 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF GORHAM ea120649ex99-2_immucellcorp.htm EX-99.2 30457
4 GRAPHIC image_001.jpg GRAPHIC 4836
5 GRAPHIC image_002.jpg GRAPHIC 6302
6 GRAPHIC image_003.jpg GRAPHIC 6131
  Complete submission text file 0001213900-20-009122.txt   93205
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 20790152
SIC: 2835 In Vitro & In Vivo Diagnostic Substances